Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+3.62%
-2.90%
+0.46%
-1.28%
Most Trending
+3.62%
-2.90%
+0.46%
-1.28%
$ALKS caught RBC Capital Markets' attention with an upgrade ahead of a key catalyst. Alkermes biotech pipeline appears to be gaining analyst confidence at a critical juncture, with RBC positioning ahead of what could be significant clinical or regulatory news.
$BIDU received dual analyst support as DBS Bank upgraded the Chinese tech giant from Hold to Buy while Goldman Sachs lifted its price target to $154 from $90, maintaining a Buy rating. Goldman specifically highlighted how Baidu's decline trajectory is already well understood and reflected in street earnings estimates.
$CIEN surged after Rosenblatt upgraded the networking equipment maker on AI infrastructure opportunities. The upgrade from Neutral to Buy with a price target increase reflects growing analyst confidence in Ciena's positioning within the AI buildout theme. Volume of 2.90 million shares slightly exceeded the 2.85 million average, indicating measured institutional interest.
$GH received significant analyst backing with upgrades from Wolfe Research from Peer Perform to Outperform, while multiple firms including UBS, Mizuho, Stifel, Guggenheim, BTIG, and Leerink Partners maintained Buy or Outperform ratings. Despite the analyst chorus, Guardant Health declined to $60.03, suggesting the market may have already priced in the positive sentiment around the liquid biopsy company's prospects.
$INTC Seaport Global upgraded the semiconductor giant from Sell to Neutral, representing a notable shift in analyst sentiment. Intel's massive volume of 248.53 million shares, nearly double the 135.83 million average, indicates significant institutional repositioning following the upgrade. While only moving to Neutral, the upgrade removes a prominent sell rating that may have been weighing on sentiment.
$KVUE Rothschild's upgrade after the Tylenol scare wiped approximately $10 billion in market value. The upgrade suggests analysts view the recent selloff as overdone, creating a potential value opportunity in the consumer health giant. Volume of 44.88 million shares exceeded the 30.17 million average, indicating renewed institutional interest.
$MAC delivered the day strongest upgrade-driven performance, soaring 6.80% to $17.90 after Bank of America upgraded the REIT to Buy, citing a higher growth path to lower leverage. Macerich's volume of 4.04 million shares more than doubled the typical 1.80 million, suggesting the upgrade triggered significant repositioning in the retail real estate space.
$MDB received an upgrade outlook from Citizens JMP, with analyst Patrick Walravens raising the price target to $375 from $345 while maintaining a Market Outperform rating following the company's investor day.
$NFLX Loop Capital upgraded the streaming giant to Buy with a lifted price target. Netflix's modest reaction on relatively light volume of 1.45 million versus 2.83 million average suggests the upgrade may have been anticipated or the target increase was conservative relative to current momentum.
$OGS Mizuho upgrade, with the analyst noting the utility is positioned to recapture its historical premium. ONE Gas saw increased volume of 521,690 shares compared to the 425,620 average, indicating the upgrade resonated with income-focused investors seeking quality utility exposure.
09:23 AM
09:16 AM
Yesterday at 09:08
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.